CKDNapp

Publikationen

2022

Bächle, H., P. Sekula, P. Schlosser, I. Steinbrenner, Y. Cheng, F. Kotsis, H. Meiselbach, H. Stockmann, S. Schönherr, G. investigators, K.-U. Eckardt, O. Devuyst, J. Scherberich, A. Köttgen and U. T. Schultheiss (2022). "Uromodulin and its association with urinary metabolites: the German Chronic Kidney Disease Study." Nephrology Dialysis Transplantation. CKDNapp doi.org/10.1093/ndt/gfac187.

Ben Guebila, M., D. Weighill, C. M. Lopes-Ramos, R. Burkholz, R. T. Pop, K. Palepu, M. Shapoval, M. Fagny, D. Schlauch, K. Glass, M. Altenbuchinger, M. L. Kuijjer, J. Platig and J. Quackenbush (2022). "An online notebook resource for reproducible inference, analysis and publication of gene regulatory networks." Nature Methods 19(5): 511-513. CKDNapp doi.org/10.1038/s41592-022-01479-2.

Cheng, Y., Y. Li, N. Scherer, F. Grundner-Culemann, T. Lehtimäki, B. H. Mishra, O. T. Raitakari, M. Nauck, K.-U. Eckardt, P. Sekula and U. T. Schultheiss (2022). "Genetics of osteopontin in patients with chronic kidney disease: The German Chronic Kidney Disease study." PLos Genet 18(4): e1010139. CKDNapp doi.org/10.1371/journal.pgen.1010139.

Cheng, Y., Y. Li, N. Scherer, F. Grundner-Culemann, T. Lehtimäki, B. H. Mishra, O. T. Raitakari, M. Nauck, K.-U. Eckardt, P. Sekula, U. T. Schultheiss and G. i. on behalf of the (2022). "Genetics of osteopontin in patients with chronic kidney disease: The German Chronic Kidney Disease study." PLOS Genetics 18(4): e1010139. CKDNapp doi.org/10.1371/journal.pgen.1010139.

Kheirkhah, A., C. Lamina, B. Kollerits, J. F. Schachtl-Riess, U. T. Schultheiss, L. Forer, P. Sekula, F. Kotsis, K.-U. Eckardt and F. Kronenberg (2022). "PCSK9 and Cardiovascular Disease in Individuals with Moderately Decreased Kidney Function." CJASN 17(6): 809–818. CKDNapp doi.org/10.2215/CJN.01230122.

Li, Y., Y. Cheng, F. Consolato, G. Schiano, M. R. Chong, M. Pietzner, N. Q. H. Nguyen, N. Scherer, M. L. Biggs, M. E. Kleber, S. Haug, B. Göçmen, M. Pigeyre, P. Sekula, I. Steinbrenner, P. Schlosser, C. B. Joseph, J. A. Brody, M. E. Grams, C. Hayward, U. T. Schultheiss, B. K. Krämer, F. Kronenberg, A. Peters, J. Seissler, D. Steubl, C. Then, M. Wuttke, W. März, K.-U. Eckardt, C. Gieger, E. Boerwinkle, B. M. Psaty, J. Coresh, P. J. Oefner, G. Pare, C. Langenberg, J. E. Scherberich, B. Yu, S. Akilesh, O. Devuyst, L. Rampoldi and A. Köttgen (2022). "Genome-wide studies reveal factors associated with circulating uromodulin and its relationships to complex diseases." JCI Insight 7(10). CKDNapp doi.org/10.1172/jci.insight.157035.

Mielke, J., H. Trucks-Jansen, C. Schurmann, F. Kotsis, A. Kottgen, M. P. Schneider, K. U. Eckardt, G. Investigators, D. F. Freitag, F. Eitner and M. S. Becker (2022). "Prevalence, phenotypic characteristics and prognostic role of apparent treatment resistant hypertension in the German Chronic Kidney Disease (GCKD) study." J Hum Hypertens. CKDNapp www.ncbi.nlm.nih.gov/pubmed/35534618.

Schrod, S., A. Schäfer, S. Solbrig, R. Lohmayer, W. Gronwald, P. J. Oefner, T. Beißbarth, R. Spang, H. U. Zacharias and M. Altenbuchinger (2022). "BITES: balanced individual treatment effect for survival data." Bioinformatics 38(Supplement_1): i60–i67. CKDNapp doi.org/10.1093/bioinformatics/btac221.

Schultheiss, U. T., H. Bächle, M. Altenbuchinger, H. Meiselbach, R. Kosch, S. Salloch, T. Bratan, H. U. Zacharias and F. Kotsis (2022). MO474: Expectation and Acceptance of a Clinical Decision Support Software by Nephrologist End-Users: The Ckdnapp Survey. 59th ERA Congress. Paris & Virtual, Nephrol Dial Transplant. 37.

Steinbrenner, I., P. Sekula, F. Kotsis, M. von Cube, Y. Cheng, J. Nadal, M. Schmid, M. P. Schneider, V. Krane, M. Nauck, K.-U. Eckardt, U. T. Schultheiss and t. G. investigators (2022). "Association of osteopontin with kidney function and kidney failure in chronic kidney disease patients: the GCKD study." Nephrology Dialysis Transplantation. CKDNapp doi.org/10.1093/ndt/gfac173.

Winitzki, D., H. U. Zacharias, J. Nadal, S. Baid-Agrawal, E. Schaeffner, M. Schmid, M. Busch, M. M. Bergmann, U. Schultheiss, F. Kotsis, H. Stockmann, H. Meiselbach, G. Wolf, V. Krane, C. Sommerer, K.-U. Eckardt, M. P. Schneider, G. Schlieper, J. Floege and T. Saritas (2022). "Educational Attainment Is Associated With Kidney and Cardiovascular Outcomes in the German CKD (GCKD) Cohort." Kidney International Reports 7(5): 1004–1015. CKDNapp doi.org/10.1016/j.ekir.2022.02.001.

Zacharias, H. U., M. Altenbuchinger, U. T. Schultheiss, J. Raffler, F. Kotsis, S. Ghasemi, I. Ali, B. Kollerits, M. Metzger, I. Steinbrenner, P. Sekula, Z. A. Massy, C. Combe, P. A. Kalra, F. Kronenberg, B. Stengel, K. U. Eckardt, A. Kottgen, M. Schmid, W. Gronwald, P. J. Oefner and G. Investigators (2022). "A Predictive Model for Progression of CKD to Kidney Failure Based on Routine Laboratory Tests." Am J Kidney Dis 79(2): 217-230 e211. CKDNapp www.ncbi.nlm.nih.gov/pubmed/34298143.

2021

Kotsis, F., U. T. Schultheiss, M. Wuttke, P. Schlosser, J. Mielke, M. S. Becker, P. J. Oefner, E. D. Karoly, R. P. Mohney, K. U. Eckardt, P. Sekula, A. Kottgen and G. Investigators (2021). "Self-Reported Medication Use and Urinary Drug Metabolites in the German Chronic Kidney Disease (GCKD) Study." J Am Soc Nephrol 32(9): 2315-2329. CKDNapp www.ncbi.nlm.nih.gov/pubmed/34140400.

Lotta, L. A., M. Pietzner, I. D. Stewart, L. B. L. Wittemans, C. Li, R. Bonelli, J. Raffler, E. K. Biggs, C. Oliver-Williams, V. P. W. Auyeung, J. a. Luan, E. Wheeler, E. Paige, P. Surendran, G. A. Michelotti, R. A. Scott, S. Burgess, V. Zuber, E. Sanderson, A. Koulman, F. Imamura, N. G. Forouhi, K.-T. Khaw, M. Bahlo, J. L. Griffin, A. M. Wood, G. Kastenmüller, J. Danesh, A. S. Butterworth, F. M. Gribble, F. Reimann, M. Bahlo, E. Fauman, N. J. Wareham, C. Langenberg and M. Consortium (2021). "A cross-platform approach identifies genetic regulators of human metabolism and health." Nat Genet 53(1): 54–64. CKDNapp doi.org/10.1038/s41588-020-00751-5.

Pammer, L. M., C. Lamina, U. T. Schultheiss, F. Kotsis, B. Kollerits, H. Stockmann, J. Lipovsek, H. Meiselbach, M. Busch, K.-U. Eckardt and F. Kronenberg (2021). "Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort." J Intern Med 290(6): 1219–1232. CKDNapp doi.org/10.1111/joim.13355.

Pietzner, M., I. D. Stewart, J. Raffler, K.-T. Khaw, G. A. Michelotti, G. Kastenmüller, N. J. Wareham and C. Langenberg (2021). "Plasma metabolites to profile pathways in noncommunicable disease multimorbidity." Nat. Med. 27(3): 471–479. CKDNapp doi.org/10.1038/s41591-021-01266-0.

Schultheiss, U. T., R. Kosch, F. Kotsis, M. Altenbuchinger and H. U. Zacharias (2021). "Chronic Kidney Disease Cohort Studies: A Guide to Metabolome Analyses." Metabolites 11(7). CKDNapp doi.org/10.3390/metabo11070460.

Schultheiss, U. T. and P. Sekula (2021). "The Promise of Metabolomics in Decelerating CKD Progression in Children." CJASN 16(8): 1152–1154. CKDNapp doi.org/10.2215/CJN.07400521.

Schultheiss, U. T., I. Steinbrenner, M. Nauck, M. P. Schneider, F. Kotsis, S. Baid-Agrawal, E. Schaeffner, K.-U. Eckardt, A. Köttgen, P. Sekula, K.-U. Eckardt, H. Meiselbach, M. P. Schneider, M. Schiffer, H.-U. Prokosch, B. Bärthlein, A. Beck, D. Kraska, A. Reis, A. B. Ekici, S. Becker, D. Becker-Grosspitsch, U. Alberth-Schmidt, B. Hausknecht, A. Weigel, G. Walz, A. Köttgen, U. T. Schultheiß, F. Kotsis, S. Meder, G. Schlieper, E. Schaeffner, S. Baid-Agrawal, K. Theisen, H. Haller, J. Menne, M. Zeier, C. Sommerer, R. Woitke, G. Wolf, M. Busch, R. Paul, T. Sitter, C. Wanner, V. Krane, A. Börner-Klein, B. Bauer, J. Raschenberger, B. Kollerits, L. Forer, S. Schönherr, H. Weissensteiner, P. Oefner, W. Gronwald, M. Schmid and J. Nadal (2021). "Thyroid function, renal events and mortality in chronic kidney disease patients: the German Chronic Kidney Disease study." Clin Kidney J 14(3): 959-968. CKDNapp doi.org/10.1093/ckj/sfaa052.

Steinbrenner, I., U. T. Schultheiss, F. Kotsis, P. Schlosser, H. Stockmann, R. P. Mohney, M. Schmid, P. J. Oefner, K. U. Eckardt, A. Kottgen, P. Sekula and I. German Chronic Kidney Disease (2021). "Urine Metabolite Levels, Adverse Kidney Outcomes, and Mortality in CKD Patients: A Metabolome-wide Association Study." Am J Kidney Dis 78(5): 669-677 e661. CKDNapp www.ncbi.nlm.nih.gov/pubmed/33839201.

Zacharias, H. U., J. Hertel, H. Johar, M. Pietzner, K. Lukaschek, S. Atasoy, S. Kunze, H. Volzke, M. Nauck, N. Friedrich, G. Kastenmuller, H. J. Grabe, C. Gieger, J. Krumsiek and K. H. Ladwig (2021). "A metabolome-wide association study in the general population reveals decreased levels of serum laurylcarnitine in people with depression." Mol Psychiatry 26(12): 7372-7383. CKDNapp doi.org/10.1038/s41380-021-01176-0.

2020

Bonk, S., J. Hertel, H. U. Zacharias, J. Terock, D. Janowitz, G. Homuth, M. Nauck, H. Völzke, H. Meyer zu Schwabedissen, S. Van der Auwera and H. J. Grabe (2020). "Vitamin D moderates the interaction between 5-HTTLPR and childhood abuse in depressive disorders." Sci Rep 10(22394): 1–9. IntegraMent & CKDNapp doi.org/10.1038/s41598-020-79388-7.

Fazzini, F., C. Lamina, J. Raschenberger, U. T. Schultheiss, F. Kotsis, S. Schönherr, H. Weissensteiner, L. Forer, I. Steinbrenner, H. Meiselbach, B. Bärthlein, C. Wanner, K.-U. Eckardt, A. Köttgen, F. Kronenberg and G. Investigators (2020). "Results from the German Chronic Kidney Disease (GCKD) study support association of relative telomere length with mortality in a large cohort of patients with moderate chronic kidney disease." Kidney International. CKDNapp doi.org/10.1016/j.kint.2020.02.034.

Pietzner, M., E. Wheeler, J. Carrasco-Zanini, J. Raffler, N. Kerrison, E. Oerton, V. Au Yeung, J. Luan, C. Finan, J. Casas, R. Ostroff, S. Williams, G. Kastenmüller, M. Ralser, E. Gamazon, N. Wareham, A. Hingorani and C. Langenberg (2020). "Genetic architecture of host proteins involved in SARS-CoV-2 infection." Nature Communications. CKDNapp doi.org/10.17863/CAM.59991.

Sekula, P., A. Tin, U. T. Schultheiss, S. Baid-Agrawal, R. P. Mohney, I. Steinbrenner, B. Yu, S. Luo, E. Boerwinkle, K.-U. Eckardt, J. Coresh, M. E. Grams and A. Kӧttgen (2020). "Urine 6-Bromotryptophan: Associations with Genetic Variants and Incident End-Stage Kidney Disease." Sci Rep 10(10018): 1–11. CKDNapp doi.org/10.1038/s41598-020-66334-w.

 

In den Medien

Studie findet Biomarker für Depressionen (CKDNapp)

Diese Seite nutzt Website Tracking-Technologien von Dritten, um ihre Dienste anzubieten. Ich bin damit einverstanden und kann meine Einwilligung jederzeit mit Wirkung für die Zukunft widerrufen oder ändern.

Einstellungen Akzeptieren ImpressumDatenschutz